P45452 (MMP13_HUMAN) Homo sapiens (Human)
Collagenase 3 UniProtKBInterProSTRINGInteractive Modelling
471 aa; Sequence (Fasta)
Available Structures
49 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human collagenase 3 (MMP-13) with peptide from pro-domain |
Heteromer | 99.73 | 2×ZN; 4×CA; 2×CL; 12×EDO; | |||
| Human collagenase 3 (MMP-13) full form with peptides from pro-domain |
Heteromer | 99.73 | 2×ZN; 5×CA; 1×CL; 11×PGO; 1×PEG; | |||
| Human collagenase 3 (MMP-13) full form with peptides from pro-domain |
Heteromer | 99.73 | 2×ZN; 5×CA; 2×CL; 3×GOL; 16×PGO; 5×PEG; | |||
| Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/M… |
Heteromer P16368; | 100 | 2×ZN; 2×CA; | |||
| MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydro… | homo-8-mer | 100 | 16×ZN; 24×CA; 8×GG1; 4×HAE; | |||
| MMP-13 complexed with 2-Napthylsulfonamide hydroxamic acid inhibitor | homo-4-mer | 100.0 | 8×ZN; 14×CA; 4×E41; 10×GOL; | |||
| Crystal Structure of MMP-13 Complexed with Inhibitor 24f | homo-4-mer | 100.0 | 8×ZN; 14×CA; 4×24F; | |||
| MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22 | homo-4-mer | 100 | 2×3W5; 4×HAE; 4×GOL; 8×ZN; 8×CA; 4×NA; 2×3W4; | |||
| Mmp13 in complex with a reverse hydroxamate Zn-binder | homo-2-mer | 100.0 | 4×ZN; 4×CA; 2×NA; 2×AZ4; | |||
| MMP13 in complex with a novel selective non zinc binding inhibitor | homo-2-mer | 100.0 | 2×5EL; 4×ZN; 4×CA; 3×NA; | |||
| X-RAY Co-structure of MMP-13 with 4-[({5-[2-(ethoxycarbonyl)-1H-indol-5-yl]-1-methyl-1H-pyrazol-3-y… | homo-2-mer | 100 | 4×ZN; 6×CA; 2×4UF; | |||
| Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | homo-2-mer | 100 | 4×ZN; 4×CA; 2×PB5; | |||
| X-RAY Co-structure of MMP-13 with ethyl 5-carbamoyl-1H-indole-2-carboxylate | homo-2-mer | 100.0 | 2×4UM; 4×ZN; 6×CA; | |||
| MMP-13 in complex with a non zinc-chelating inhibitor | homo-2-mer | 100.0 | 4×ZN; 6×CA; 2×FMT; 1×732; | |||
| Mmp13 in complex with a piperazine hydantoin ligand | homo-2-mer | 100.0 | 4×ZN; 4×CA; 2×NA; 2×AZ6; | |||
| X-RAY Co-structure of MMP-13 with ethyl 5-(1-methyl-1H-imidazol-5-yl)-1H-indole-2-Carboxylate | homo-2-mer | 100.0 | 4×ZN; 6×CA; 2×4UE; | |||
| MMP-13 in complex with a non zinc-chelating inhibitor | homo-2-mer | 100.0 | 4×ZN; 6×CA; 1×518; | |||
| MMP-13 in complex with the peptide IMISF | homo-2-mer | 100.0 | 2×ZN; 3×CA; 1×GOL; | |||
| CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC… | homo-2-mer | 100 | 4×ZN; 2×CA; 2×CBP; | |||
| Matrix metalloproteinase-13 complexed with selective inhibitor compound (R)-17a | homo-2-mer | 100.0 | 2×ZN; 3×CA; 1×8OA; | |||
| COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN | monomer | 100 | 1×SO4; 2×CL; 2×CA; | |||
| SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NO… | monomer | 100 | 2×ZN; 2×CA; 1×HAV; 1×3MP; 1×MSB; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with N-phenyl-4-((4H-1,2,4-triazol-3-… | monomer | 100.0 | 2×ZN; 2×CA; 1×NA; 1×EDO; 1×WMM; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-di… | monomer | 100.0 | 2×ZN; 2×CA; 1×NA; 1×FMT; 1×EDO; 1×WLL; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxyben… | monomer | 100 | 2×ZN; 2×CA; 1×NA; 1×FMT; 1×WHH; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with 4-oxo-N-(3-(2-(1H-1,2,4-triazol-… | monomer | 100.0 | 2×ZN; 3×CA; 1×WNN; | |||
| Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | monomer | 100 | 2×ZN; 2×CA; 1×PB3; | |||
| Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | monomer | 100 | 2×ZN; 2×CA; 1×PB4; | |||
| X-ray structure of MMP-13 in Complex with 4-(1,2,3-thiadiazol-4-yl)pyridine | monomer | 100.0 | 2×ZN; 2×CA; 1×9DY; 6×FMT; 1×PGE; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-di… | monomer | 100.0 | 2×ZN; 2×CA; 1×NA; 1×WGG; | |||
| Human MMP13 in complex with L-glutamate motif inhibitor | monomer | 100 | 2×ZN; 3×CA; 1×E3P; 3×PEG; | |||
| COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID | monomer | 100.0 | 2×ZN; 1×CA; 1×RS1; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibi… | monomer | 100 | 2×ZN; 1×CA; 2×SO4; 1×PFD; | |||
| Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor | monomer | 100 | 2×ZN; 3×CA; 1×SO4; 1×SP6; 1×HAE; | |||
| Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1 | monomer | 100 | 3×ZN; 2×CA; 1×FMT; 2×1UA; 1×GOL; | |||
| Collagenase-3 (MMP-13) complexed to a hydroxamic acid inhibitor | monomer | 100 | 4×ZN; 3×CA; 1×FA4; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033 | monomer | 100.0 | 2×ZN; 3×CA; 1×033; | |||
| Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344 | monomer | 100.0 | 2×ZN; 3×CA; 1×347; | |||
| Crystal structure of MMP-13 in complex with SC-78080 | monomer | 100 | 2×ZN; 2×CA; 1×3KR; | |||
| Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound | monomer | 100 | 2×ZN; 3×CA; 1×3EK; | |||
| Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound | monomer | 99.38 | 2×CA; 2×ZN; 2×SO4; 1×LA3; | |||
| Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-10a | monomer | 100.0 | 2×ZN; 3×CA; 1×8OM; | |||
| MMP-13 in complex with selective tetrazole core inhibitor | monomer | 100 | 1×3O2; 2×ZN; 2×CA; 3×SO4; 1×EPE; | |||
| Crystal Structure of Human MMP-13 complexed with a phenyl-2H-tetrazole compound | monomer | 100 | 2×ZN; 3×CA; 2×SO4; 1×3KE; 1×HAE; | |||
| Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound | monomer | 100 | 2×ZN; 3×CA; 1×3EJ; | |||
| Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d | monomer | 100 | 2×ZN; 2×CA; 1×8O7; 2×SO4; | |||
| Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-17a | monomer | 100 | 2×ZN; 3×CA; 1×8OJ; | |||
| SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDRO… | monomer | 100 | 2×ZN; 1×CA; 1×WAY; | |||
| SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDRO… | monomer | 100 | 2×ZN; 1×CA; 1×WAY; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1su3.1.A | monomer | 0.78 | 2×ZN; | 50.00 | ||
| 3ba0.1.A | monomer | 0.75 | 2×ZN; 1×CA; 1×HAE; | 49.72 | ||
| 1l6j.1.A | monomer | 0.61 | 1×ZN; 1×CA; | 49.27 | ||